Zhang, Haiyan

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

Tang, R., Wei, Y., Li, Y., Chen, W., Chen, H., Wang, Q., Yang, F., Miao, Q., Xiao, X., Zhang, H., et al. (2018) · Gut

Gut microbiota and healthLiver Diseases and Immunity

Cited by 434

A genome-wide association study identifies six novel risk loci for primary biliary cholangitis

Qiu, F., Tang, R., Zuo, X., Shi, X., Wei, Y., Zheng, X., Dai, Y., Gong, Y., Wang, L., Xu, P., et al. (2017) · Nature Communications

Liver Diseases and ImmunityGenetic Associations and Epidemiology

Cited by 140

A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice

Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 134

The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis

Yang, F., Wang, Q., Wang, Z., Miao, Q., Xiao, X., Tang, R., Chen, X., Bian, Z., Zhang, H., Yang, Y., et al. (2016) · Clinical Reviews in Allergy & Immunology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 71

A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation

Zhang, H., Lian, M., Zhang, J., Bian, Z., Tang, R., Miao, Q., Peng, Y., Fang, J., You, Z., Invernizzi, P., et al. (2018) · Hepatology

Liver Diseases and ImmunityImmune cells in cancer

Cited by 61

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

Qiu, M.-Z., Wang, C., Wu, Z., Zhao, Q., Zhao, Z., Huang, C.-Y., Wu, W., Yang, L.-Q., Zhou, Z.-W., Zheng, Y., et al. (2023) · Signal Transduction and Targeted Therapy

Cancer Immunotherapy and BiomarkersViral-associated cancers and disorders

Cited by 58